Clarifying State Action Immunity under the Antitrust Laws: FTC v. Phoebe Putney Health System, Inc.

25 St. Thomas Law Review 73 (2012)

32 Pages Posted: 5 Aug 2012 Last revised: 26 Feb 2013

Date Written: January 30, 2013

Abstract

The tension between federalism and national competition policy has come to a head. The state action doctrine finds its basis in principles of federalism, permitting states to replace free competition with alternative regulatory regimes they believe better serve the public interest. Public restraints have a unique ability to undermine the regime of free competition that provides the basis of U.S.- and state-commerce policies. Nevertheless, preservation of federalism remains an important rationale for protecting such restraints. The doctrine has elusive contours, however, which have given rise to circuit splits and overbroad application that threatens to subvert the state action doctrine’s dual goals of federalism and competition. The recent Eleventh Circuit decision in FTC v. Phoebe Putney Health System, Inc. epitomizes the concerns associated with misapplication of state action immunity. The U.S. Supreme Court recently granted the FTC’s petition for certiorari and now has the opportunity to more clearly define the contours of the doctrine. In Phoebe Putney, the FTC has challenged a merger it claims is the product of a sham transaction, an allegation certain to test the boundaries of the state action doctrine and implicate the interpretation of a two-pronged test designed to determine whether consumer welfare-reducing conduct taken pursuant to purported state authorization is immune from antitrust challenge. The FTC’s petition for writ of certiorari raises two issues for review. First, it presents the question concerning the appropriate interpretation of foreseeability of anticompetitive conduct. Second, the FTC presents the question whether a passive supervisory role on the state’s part can be construed as state action or whether its approval of the merger was a sham. In this paper, I seek to explicate the areas in which the state action doctrine needs clarification and to predict how the Court will decide the case in light of precedent and the principles underlying the doctrine.

Keywords: antitrust, FTC, federal trade commission, phoebe putney, state action doctrine, state action immunity, mergers, regulation, federalism, competition

Suggested Citation

Diveley, Angela, Clarifying State Action Immunity under the Antitrust Laws: FTC v. Phoebe Putney Health System, Inc. (January 30, 2013). 25 St. Thomas Law Review 73 (2012), Available at SSRN: https://ssrn.com/abstract=2123677 or http://dx.doi.org/10.2139/ssrn.2123677

Angela Diveley (Contact Author)

Weil, Gotshal & Manges LLP ( email )

Washington, DC
United States

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
150
Abstract Views
1,451
Rank
352,966
PlumX Metrics